Chengdu Kanghua Biological Products (300841) — Cash Flow-to-Debt Ratio
Chengdu Kanghua Biological Products (300841) has a Cash Flow-to-Debt Ratio of 0.22x as of September 2025, meaning its operating cash flow of CN¥92.89 Million could theoretically repay 0% of its total liabilities (CN¥430.82 Million) in one year. See 300841 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Chengdu Kanghua Biological Products Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Chengdu Kanghua Biological Products across 10 annual periods. Also explore net asset growth rate of Chengdu Kanghua Biological Products to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Chengdu Kanghua Biological Products (2015–2024)
Year-by-year debt coverage analysis for Chengdu Kanghua Biological Products. For market capitalisation and broader financial context, see Chengdu Kanghua Biological Products market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | CN¥572.24 Million | CN¥580.07 Million | ▲ +19.5% |
| 2023 | 0.83x | CN¥573.98 Million | CN¥695.22 Million | ▲ +169.0% |
| 2022 | 0.31x | CN¥194.99 Million | CN¥635.40 Million | ▼ -18.1% |
| 2021 | 0.37x | CN¥130.33 Million | CN¥347.74 Million | ▼ -82.4% |
| 2020 | 2.13x | CN¥369.56 Million | CN¥173.24 Million | ▲ +33.7% |
| 2019 | 1.60x | CN¥182.73 Million | CN¥114.49 Million | ▲ +229.4% |
| 2018 | 0.48x | CN¥57.35 Million | CN¥118.37 Million | ▼ -53.5% |
| 2017 | 1.04x | CN¥89.96 Million | CN¥86.38 Million | ▲ +11610.7% |
| 2016 | 0.01x | CN¥2.64 Million | CN¥297.23 Million | ▼ -62.7% |
| 2015 | 0.02x | CN¥6.51 Million | CN¥272.61 Million | — |